Read + Share
Amedeo Smart
Independent Medical Education
Chedid T, Moisset X, Clavelou P. Rationale for off-label treatments use in primary progressive multiple sclerosis: A review of the literature. Rev Neurol (Paris) 2022 Jul 15. pii: S0035-3787(22)00639.PMID: 35851485
Email
LinkedIn
Facebook
Twitter
Privacy Policy